MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-24-0024587
Cureta Pharma Private Limited
Cureta Pharma Private Limited - business services in Jabalpur, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.66 Lakh
▲ 86% YoY
Net profit · FY 2025
₹43,076
Net margin 3.7%
EBITDA · FY 2025
₹78,661
EBITDA margin 6.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹9 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Cureta Pharma Private Limited
Data last updated:
Cureta Pharma Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 13 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2021PTC056671.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ruchi Shukla and Parul Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 462793 – Professor Colony Suhagi Road Adhartal, Jabalpur, Madhya Pradesh, India – 482001.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.66 Lakh, a growth of 86% compared to the previous year. For the same year it recorded a net profit of ₹43,076 (net margin 3.7%) and EBITDA of ₹78,661 (EBITDA margin 6.7%).
As per MCA filings, the company has open charges of ₹9 Lakh on record.
Cureta Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-24-0024587).
Company details
CIN U74999MP2021PTC056671
Registration Number 056671
Incorporation Date 13 July 2021
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-24-0024587
Key People
Ruchi Shukla Director Parul Tripathi Director Recognitions & Rankings of Cureta Pharma
Contact details
Cureta Pharma Private Limited's registered office is in Jabalpur, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address462793 – Professor Colony Suhagi Road Adhartal, Jabalpur, Madhya Pradesh, India – 482001
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Cureta Pharma Private Limited, buy the company report.
Comprehensive company report
Cureta Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cureta Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Cureta Pharma Private Limited, buy the company report.
Financials of Cureta Pharma Private Limited
FY 2025 filings availableCureta Pharma Private Limited reported revenue of ₹11.66 Lakh (up 86% YoY) for FY 2025.
Revenue · FY 2025
₹11.66 Lakh ▲ 86%
Net profit · FY 2025
₹43,076 margin 3.7%
EBITDA · FY 2025
₹78,661 margin 6.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 86%
EBITDA CAGR growth
1 year
▲ 205%
3 years · compounded
▲ 128%
Revenue rose 86% in the latest year. EBITDA rose 205% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹78,661 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹43,076 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.7% | |||
| Net Profit Margin | 3.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Cureta Pharma Private Limited, buy the company report.
Board of directors of Cureta Pharma Private Limited
Cureta Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruchi Shukla | Director | 13 Jul 2021 | 5 Years 3 Months | Current |
| Parul Tripathi | Director | 13 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Cureta Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jagaddhatri Data Analytics and Engineering Private Limited | ₹12.04 Lakh (FY 2025) | 26.0% | Kolkata, West Bengal, India | |||
| Diabello Healthcare Private Limited | ₹12.02 Lakh (FY 2024) | Nashik, Maharashtra, India | ||||
| Canary Biosensors Private Limited | ₹11.81 Lakh (FY 2024) | Sriperumbudur, Tamil Nadu, India | ||||
| Tnine Pharmaceuticals Private Limited | ₹11.78 Lakh (FY 2025) | 2617.0% | Mumbai, Maharashtra, India | |||
| Ranvet Pharmaceuticals Private Limited | ₹11.77 Lakh (FY 2025) | Kichha, Uttarakhand, India | ||||
| Cureta Pharma Private Limitedthis company | ₹11.66 Lakh (FY 2025) | ₹43,076 | 3.7% | 86.0% | Jabalpur, Madhya Pradesh, India | |
| Dapica Pharmaceuticals Private Limited | ₹11.61 Lakh (FY 2025) | 99.0% | Badlapur, Maharashtra, India | |||
| Velocity Healthcare India Private Limited | ₹11.45 Lakh (FY 2025) | -42.0% | New Delhi, Delhi, India | |||
| Jaiwanti Pharmacare Private Limited | ₹11.42 Lakh (FY 2025) | Paonta Sahib, Himachal Pradesh, India | ||||
| Ranga Pharmaceuticals Private Limited | ₹11.28 Lakh (FY 2024) | 644.0% | Ramanagara, Karnataka, India | |||
| RJMS Agro Private Limited | ₹11.22 Lakh (FY 2024) | Vasai, Maharashtra, India |
To see the full peer comparison of Cureta Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jun 2023 | 100796697 | Bank of India | ₹9 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cureta Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cureta Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cureta Pharma Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Cureta Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cureta Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Parul Tripathi was appointed as Director on 13 Jul 2021.
AGM
Cureta Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cureta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Bank Of India amounted to Rs. 9.00 Lakh with Charge ID 100796697 was registered on 13 Jun 2023.
Appointed
Parul Tripathi was appointed as Director.
Appointed
Ruchi Shukla was appointed as Director.
Incorporation
13 Jul 2021
Cureta Pharma Private Limited was registered on 13 Jul 2021 with Roc Gwalior & aged 5 years 3 months as per MCA records.
Frequently asked questions
Cureta Pharma is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 13 July 2021 (5+ years old) and is registered under CIN U74999MP2021PTC056671.
Cureta Pharma has 2 current directors:
- Ruchi Shukla - Director
- Parul Tripathi - Director
The latest financial statements of Cureta Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Cureta Pharma is U74999MP2021PTC056671. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cureta Pharma was incorporated on 13 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Cureta Pharma by revenue are Jagaddhatri Data Analytics and Engineering Private Limited, Diabello Healthcare Private Limited, Canary Biosensors Private Limited, Tnine Pharmaceuticals Private Limited, Ranvet Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Parul Tripathi was appointed as Director on 13 Jul 2021. Ruchi Shukla was appointed as Director on 13 Jul 2021.
Yes, Cureta Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-24-0024587).
The registered office of Cureta Pharma is at 462793 – Professor Colony Suhagi Road Adhartal, Jabalpur, Madhya Pradesh, India – 482001.
Cureta Pharma operates in the business services industry, in the miscellaneous business activities segment.
Cureta Pharma has open charges of ₹9 Lakh and no satisfied charges on record as per latest MCA filings.